Aralez Pharmaceuticals (ARZ) Shares Up -2.3%

Aralez Pharmaceuticals Inc (TSE:ARZ)’s share price shot up 2.3% on Thursday . The company traded as high as C$2.19 and last traded at C$2.12. 12,539 shares traded hands during mid-day trading, a decline of 76% from the average session volume of 53,007 shares. The stock had previously closed at C$2.17.

The stock has a market capitalization of $120.53 and a price-to-earnings ratio of -1.33.

COPYRIGHT VIOLATION WARNING: This piece was published by Stock Observer and is the sole property of of Stock Observer. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.thestockobserver.com/2018/01/13/aralez-pharmaceuticals-arz-shares-up-2-3.html.

Aralez Pharmaceuticals Company Profile

Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.

Receive News & Ratings for Aralez Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply